More recently, overexpression of enhancer of zeste homolog 2 (EZH2), an H3K27-specific histone methyltransferase with an oncogenic role in NKTCL, was shown to be significantly associated with higher tumor cell proliferation, advanced stage, and higher risk of death [53]. Here, EZH2 is linked to extranodal nasal NK/T cell lymphoma.